CDC Links 4 More States to Cyclospora Outbreak as Produce Tracing Expands
ATLANTA — Federal health officials have expanded their investigation into a growing multistate outbreak of cyclosporiasis, linking four additional...
FDA Approves Outlook Therapeutics’ Lytenava for Wet AMD, Delivering the First Dedicated Ophthalmic Bevacizumab to Retina Care
Published: July 25, 2026 WASHINGTON — In a major milestone for retina care, the U.S. Food and Drug Administration (FDA) has approved Outlook...
Merck Secures Early Generic Access Deals in 129 Nations for Experimental Once-Monthly HIV Prevention Pill
RAHWAY, N.J. — In an unusual move to shorten global drug delivery timelines, pharmaceutical giant Merck announced on July 23–24, 2026, that it has...
U.S. Measles Surge Surpasses 2,300 Cases in 2026, Marking Highest Level in 35 Years
WASHINGTON — Confirmed U.S. measles cases have reached 2,318 so far in 2026, eclipsing last year’s entire annual total of 2,289 infections with five...
FDA Approves First OTC Tylenol-Naproxen Combination Pill, Expanding Non-Opioid Relief Options
WASHINGTON — In a major development for consumer health and pain management, the U.S. Food and Drug Administration (FDA) has approved "Tylenol with...
